MOUNJARO 5MG (TIRZEPATIDE) INJECTION is a once-weekly, prescription GLP-1 and GIP receptor agonist used to control blood sugar levels in adults with type 2 diabetes. It is the next step after the 2.5mg starting dose and helps further improve glycemic control and support weight management. Clinically proven, it delivers multi-pathway benefits with a convenient injection format.